Abstract Dopamine, acting at the D1 family receptors (D1R) is critical for the functioning of the amygdala, including fear conditioning and cue-induced reinstatement of drug self administration. However, little is known about the different contributions of the two D1R subtypes, D 1 and D 5 . We identified D 1 -immunoreactive patches in the primate that appear similar to the intercalated cell masses reported in the rodent; however, both receptors were present across the subdivisions of the primate amygdala including the basolateral amygdala (BLA). Using immunoelectron microscopy, we established that both receptors have widespread distributions in BLA. The D1R subtypes colocalize in dendritic spines and terminals, with D 1 predominant in spines and D 5 in terminals. Single-cell RT-PCR confirmed that individual BLA projection neurons express both D 1 and D 5 mRNA. The responses of primate BLA neurons to dopamine and D1R drugs were studied using in vitro slices. We found that responses were similar to those previously reported in rat BLA neurons and included a mixture of postsynaptic and presynaptic actions. We investigated the distribution of D1R in the rat BLA and found that there were similarities between the species, such as more prominent D 5 localization to presynaptic structures. The higher affinity of D 5 for dopamine suggests that presynaptic actions may predominate in the BLA at low levels of dopamine, while postsynaptic effects increase and dominate as dopaminergic drive increases. The results presented here suggest a complex action of dopamine on BLA circuitry that may evolve with different degrees of dopaminergic stimulation.
Introduction
Dopaminergic neurotransmission at D1 family receptors (D1R) is critical for the functioning of the amygdala. Hence, D1R activation in the basolateral amygdala (BLA) is necessary for the formation of cross-modal associations between conditioned stimuli and unconditioned stimuli in fear conditioning paradigms (Lamont and Kokkinidis 1998; Nader and LeDoux 1999; Guarraci et al. 1999; Greba and Kokkinidis 2000; Macedo et al. 2007) , and injections of D1R antagonists into the amygdala have anxiolytic effects (de la Mora et al. 2005) . Moreover, D1R activation in the BLA is also essential for cue-induced reinstatement of drug self-administration (Ciccocioppo et al. 2001; See et al. 2001 See et al. , 2003 Berglind et al. 2006) .
Recently, the cellular effects of dopamine activation of D1R in the amygdala have begun to be explored. D1R activation has been shown to increase the excitability of projection neurons (Kroner et al. 2005; Pickel et al. 2006; Yamamoto et al. 2007) , and inhibitory interneurons in the basolateral complex (Loretan et al. 2004; Kroner et al. 2005) , although GABAergic neurons in the intercalated cell groups are inhibited by D1R activation (Marowsky et al. 2005) . Furthermore, activation of D1R attenuates excitatory glutamatergic input onto BLA projection neurons from the prefrontal cortex (Rosenkranz and Grace 2002) , perhaps via suppressing NMDA receptor-mediated currents associated with these inputs (Pickel et al. 2006) . Clearly D1R activation plays a complex role in regulating the input-output relationship of the BLA.
Despite the established importance of D1R in the normal function of the BLA, the relationship of D1R to BLA circuitry is unclear. Critically, the D1 family of dopamine receptors consists of two separate receptors, the D 1 and D 5 receptors (Civelli et al. 1993; Gingrich and Caron 1993) . While available pharmacological tools do not differentiate between these receptors, a growing body of evidence points to important functional differences (Sunahara et al. 1991; Tiberi et al. 1991; Hersi et al. 2000; Liu et al. 2000; Lee et al. 2002; Centonze et al. 2003; Laplante et al. 2004) .
Consistent with results from D1R binding (Scibilia et al. 1992) , in the rat, low levels of D 1 mRNA have been reported in the BLA (Mansour et al. 1991 ) with higher levels of D 1 mRNA (Maltais et al. 2000) and immunolabeling (Fuxe et al. 2003; Jacobsen et al. 2006) seen in the intercalated cell groups of the amygdala. Two studies have examined the subcellular distribution of D 1 in the amygdala but with contrasting findings. In the first study of the BLA, D 1 -immunoreactivity (-IR) was reported mainly in cell bodies and dendrites, with spines and axon terminals more rarely seen (Pickel et al. 2006) . The second study in the BLA and intercalated cell groups reported that D 1 -IR was most commonly seen in dendritic spines, with dendritic shafts, axonal elements and glia less commonly seen (Pinto and Sesack 2008) . Levels of D 5 in the amygdala have not been examined directly, but low levels were inferred from studies of D1R binding in D 1 -knockout mice (Montague et al. 2001) . To date, no study has examined the subcellular distribution of D 5 receptors in the BLA.
The goal of this study was to establish the pattern of distribution of D 1 receptors in the BLA with a larger, quantitative analysis and compare that directly with the D 5 receptor distribution. We focused our work on macaque monkey tissue to better relate to our previous work on D 1 and D 5 in monkey prefrontal cortex. In addition, we used in vitro slice electrophysiology to examine some of the actions of D1R stimulation and examine whether previous findings in rat amygdala could be replicated in a nonhuman primate model. Finally, we quantified the distribution of D 1 and D 5 in rat BLA to compare to our monkey findings.
Materials and methods

Antisera
Two antibodies were used in this study. The rat anti-D 1 antiserum (Sigma-Aldrich, St. Louis, MO, #D187) was prepared against a 97 amino acid synthetic peptide corresponding to the C-terminus of the human D 1 receptor. The antiserum stains two major bands at 40-45 and 65-75 kD (Hersch et al. 1995) , and all staining at the light and electron microscopic levels was abolished when the antiserum was preincubated with 0.5 mg/ml of D 1 -GST fusion protein (Smiley et al. 1994) . The D 5 antiserum was a rabbit polyclonal antiserum raised against residues 428-438 of the D 5 receptor. This sequence is common to both rat and human D 5 receptors. This antiserum reacts to D 5 -expressing recombinant Sf9 cells but not Sf9 cells expressing D 1 , D 2 , D 3 or D 4 (Khan et al. 2000) . Western blot in macaque PFC, striatum and hippocampus labeled a single band with a molecular weight of approximately 53-54 kD (BordelonGlausier et al. 2008) , in line with the predicted molecular weight of the D 5 receptor of approximately 53 kD (Sunahara et al. 1991; Tiberi et al. 1991) . Immunohistochemical staining of macaque brain was abolished when the antiserum was pre-incubated with the cognate peptide (BordelonGlausier et al. 2008 ).
Animals and preparation of tissue for immunohistochemistry
Tissue from eight Macaca mulatta monkeys and five adult male rats were used for this study. The care of the animals and all anesthesia and sacrifice procedures in this study were performed according to the National Institutes for Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of Emory University. The animals were sacrificed with an overdose of pentobarbital (100 mg/kg) and then perfused with a flush of Tyrode's solution. The flush was followed by 4 l of fixative solution of 4% paraformaldehyde/0.2% glutaraldehyde/0-0.2% picric acid in phosphate buffer (0.1 M, pH 7.4; PB). The brain was blocked and post-fixed in 4% paraformaldehyde for 2-12 h. Coronal, 50 lm thick vibratome sections of the medial temporal lobe were cut and stored frozen at -80°C in 15% sucrose until immunohistochemical experiments were performed.
Single-label immunohistochemistry
Single-label immunoperoxidase labeling was performed using rat anti-D 1 at a 1:500 dilution or rabbit anti-D 5 antisera at 1:500. The single-label immunoperoxidase labeling for D 1 and D 5 was performed as described previously (Muly et al. 2003) . Briefly, sections were thawed, incubated in blocking serum (3% normal goat serum, 1% bovine serum albumin, 0.1% glycine, 0.1% lysine) in 0.01 M phosphate buffered saline, (PBS; pH 7.4) for 1 h and then placed in primary antiserum diluted in blocking serum. After 36 h at 4°C, the sections were rinsed and placed in a 1:200 dilution of biotinylated donkey anti-rat IgG (Jackson Immuno Research, West Grove, PA) for D 1 or goat anti-rabbit IgG (Vector, Burlingame, CA) for D 5 for 1 h at room temperature. The sections were then rinsed, placed in avidin-biotinylated peroxidase complex (ABC) (ABC Elite, Vector, Burlingame, CA) for 1 h at room temperature, and then processed to reveal peroxidase using 3,3 0 -diaminobenzidine (DAB) as the chromagen. Sections were then post-fixed in osmium tetroxide, stained en bloc with uranyl acetate, dehydrated, and embedded in Durcupan resin (Electron Microscopy Sciences, Fort Washington, PA). Selected regions were mounted on blocks, and ultrathin sections were collected onto pioloform-coated slot grids and counterstained with lead citrate. Control sections processed as above except for the omission of the primary immunoreagent, did not contain DAB label upon electron microscopic examination.
Double-label immunogold/DAB immunohistochemistry
To examine the possibility of co-localization of the two D1R subtypes, we performed double-label immunogold/ DAB experiments. In one condition D 1 was labeled with immunogold, and D 5 was labeled with DAB. In a second condition the labels were reversed. Amygdala tissue sections were thawed and rinsed in PBS. They were incubated in blocking serum (3% normal goat serum, 1% bovine serum albumin, 0.1% glycine, 0.1% lysine and 0.5% fish gelatin) in PBS for 1 h and then placed in the primary antiserum diluted at the same concentrations as the single label experiments overnight at 4°C. The sections were removed from the primary antiserum, rinsed in PBS and placed in secondary antiserum (1 nm gold conjugated goat anti-rat, used at 1:100, Nanoprobes, Yaphank, NY and biotinylated goat anti-rabbit, used at 1:200, Jackson Immuno Research, West Grove, PA; 1 nm gold conjugated goat anti-rabbit, used at 1:100, Nanoprobes, Yaphank, NY and biotinylated donkey anti-rat, used at 1:200, Jackson Immuno Research, West Grove, PA) overnight at 4°C. The tissue was then rinsed in PBS, placed in 2% glutaraldehyde for 20 min, rinsed in PBS, rinsed in 2% acetate buffer, silver-intensified for 4 min (HQ silver, Nanoprobes, Yaphank, NY), then rinsed in acetate buffer and in PBS. The sections were incubated in ABC overnight at 4°C and reacted in the same manner as the single-label material. Control sections were processed in which primary antisera were omitted or in which one primary antisera was used and matched with secondary antisera raised to the other species used in our experiments. These sections showed no evidence for nonspecific DAB or immunogold labeling or for cross-reactivity of our secondary's for the other primary antisera.
Double-label cocktail immunohistochemistry
In order to quantify the extent of co-localization of D 1 and D 5 , tissue sections were incubated in a cocktail of the primary immunoreagents rat anti-D 1 and rabbit anti-D 5 at a dilution of 1:500 and compared to tissue sections that were incubated with rat anti-D 1 alone or rabbit anti-D 5 alone at a dilution of 1:500. This cocktail procedure has been described in detail (Muly et al. 2001) , and has been used in subsequent studies (Lei et al. 2004; Mitrano and Smith 2007; Bordelon-Glausier et al. 2008) . Briefly, the tissue sections in the cocktail condition were incubated with both primary antisera, then in a cocktail of biotinylated secondary IgGs and in ABC to reveal D 1 and D 5 . DAB was used as the chromogen for both D 1 and D 5 . The D 1 alone and D 5 alone conditions were processed as described above.
Analysis of material
For our quantitative analyses in monkey BLA, four animals were used: three female, one male, ranging in age from 2 to 5 years. No differences in receptor localization related to monkey age were observed. The single-label DAB material was analyzed as previously described (Muly et al. 2003) . Blocks of tissue from the BLA were made and cut in ultrathin sections that were examined using a Zeiss EM10C electron microscope. Regions of the grids containing neuropil were selected based on the presence of label and adequate ultrastructural preservation. Fields of immunoreactive elements in the neuropil were randomly selected, and images were collected at a magnification of 31,500 using a Dualvision cooled CCD camera (1,300 9 1,030 pixels) and Digital Micrograph software (version 3.7.4, Gatan, Inc., Pleasanton, CA). Images selected for publication were saved in TIFF format and imported into an image processing program (Canvas 8; Deneba Software, Miami, FL). The contrast was adjusted, and the images were cropped to meet size requirements. For D 1 a total of 617 micrographs representing 3,767 lm 2 of BLA were analyzed across four monkeys and a total of 1,014 labeled profiles were counted. For D 5 a total of 544 micrographs representing 3,321 lm 2 of BLA were analyzed across four monkeys and a total of 994 labeled profiles were counted. For our rat studies we examined tissue from five adult male rats. In rat BLA, we examined 293 micrographs of tissue labeled for D 1 receptor, representing 1,788 lm 2 of BLA neuropil, and counted a total of 565 labeled profiles. For D 5 in the rat, we examined 244 micrographs, representing 1,489 lm 2 of BLA neuropil, and counted 479 labeled profiles.
On each micrograph, DAB-labeled profiles were identified and classified as spines, dendrites, terminals, axons, glia or unknown based on ultrastructural criteria (Peters et al. 1991) as previously described (Muly et al. 2003) . Profiles that could not be clearly characterized based on these criteria were considered unknown profiles. The number of immunoreactive profiles was tabulated and the distributions (excluding the unknown profiles) compared with a Chi-square analysis.
For the analysis of the immunogold/DAB, we examined ultrathin sections from the surface of each block where both immunoperoxidase label and immunogold label were visible. Because immunogold label can be noisy, we sought to avoid false-positive labeling by avoiding the very surface of each block, where non-specific gold particles tend to accumulate. We compared the immunogold label in a given structure to the surrounding background level of immunogold labeling, as well as the size of the silverintensified gold particles. In order for a profile to be considered immunogold labeled, it had to have two or more gold particles present, have a density of gold label of greater than two particles per square micron, and have a density of label greater than six times that observed on mitochondria in the adjacent neuropil. For the later, we determined the cross-sectional area of every identifiable mitochondria in the neuropil images (excluding any within the labeled dendrite or terminal) and calculated the background level as number of gold particles on mitochondria divided by total cross-sectional area of these profiles.
For the cocktail double-label experiments in monkey, blocks of tissue from BLA were made for the D 1 /D 5 cocktail condition, D 1 alone and D 5 alone conditions. Fields of the neuropil were randomly selected, and images were collected at a magnification of 20,000. An ANOVA sample size analysis (SigmaStat, Version 2.03, SPSS Inc.) indicated that the minimum sample size required to have a statistical power of 80% and a minimum detectable difference in group means of five was 474 images; therefore, we analyzed 629 images in the D 1 alone condition, 489 images in the D 5 alone condition and 572 images in the D 1 /D 5 cocktail condition. In each experimental condition, the number of images analyzed from each monkey was similar. The images were coded and the analysis of these images was performed by an experimenter blind to the identity of the material until all analysis was complete. On each micrograph, spines and axon terminals were identified using the previously described ultrastructural criteria (Peters et al. 1991) , then classified as immunopositive or immunonegative, and the percentage of identified spines or terminals that were immunopositive was calculated. The mean percentage of immunopositive spines and axon terminals were tabulated for each condition and compared across antigen conditions using an ANOVA. The results are reported as mean ± standard error.
In vitro brain slice experiments
The methods for obtaining in vitro brain slices were similar to those described previously in rodents (Rainnie 1999; Rainnie et al. 2006) . Briefly, blocks of unfixed amygdala tissue were placed into oxygenated ice cold ''cutting'' aCSF (130 mM NaCl, 30 mM NaHCO 3 , 3.5 mM KCl, 1.1 mM KH 2 PO 4 , 6 mM MgCl 2 , 1 mM CaCl 2 , 10 mM glucose) supplemented with 5 mM kynurenic acid to minimize glutamate-induced neurotoxicity. Tissue blocks were then glued to the stage of an OTS 4000 vibratome (Electron Microscopy Instruments) and 350 lm coronal slices of monkey amygdala were sectioned and placed in oxygenated ''cutting'' aCSF at 32°C for 1 h to recover from the sectioning procedure prior to experimentation. Slices were then transferred to control aCSF of the following composition: NaCL 130 mM, 30 mM NaHCO 3 , 3.5 mM KCl, 1.1 mM KH 2 PO 4 , 1.3 mM MgCl 2 , 2.5 mM CaCl 2 , 10 mM glucose for at least 30 min prior to the onset of whole-cell patch-clamp recording.
Electrophysiological recordings
Individual slices containing the BLA were placed in a Warner Series 20 recording chamber (Warner Instruments, Hamden, CT) mounted on the fixed stage of a Leica DM-LFS microscope (Leica Microsystems). Slices were fully submerged and continuously perfused at a rate of 1-2 ml per min with heated (32°C) and oxygenated control ACSF. Neurons were visualized using infrared (IR) illumination and a 409 water immersion objective (Leica Microsystems). Images were captured using an IR sensitive charge-coupled device (CCD) digital camera (Orca ER, Hamamatsu, Tokyo Japan) coupled to a Meteor-II video frame grabber (Matrox Electronic Systems Ltd, Dorval, Canada), and displayed on a computer monitor using Simple PCI 6.11 software (Compix Inc., Cranberry Township, PA).
For whole-cell patch-clamp recording, thin walled borosilicate glass patch electrodes (WPI, Sarasota, Fl) were pulled on a Flaming/Brown micropipette puller (Model P-97, Sutter Instruments). Patch electrodes had resistances ranging from 4 to 8 MX, when filled with a standard patch solution that contained (in mM): K-Gluconate (138), KCl (2), MgCl 2 (3) , phosphocreatine (5), K-ATP (2), NaGTP (0.2), HEPES (10). The patch recording solution was adjusted to a pH of 7.3 with KOH and had a final osmolarity of 280 mOsm. Whole-cell patch-clamp recordings were obtained as previously described (Rainnie et al. 2004 ), using an Axopatch-1D amplifier (Molecular Devices, Sunnyvale, CA), a Digidata 1320A A-D interface, and pClamp 9.2 software (Molecular Devices). In cell-attached mode, patch electrode seal resistance was considered acceptable if it was [1.5 GX. Whole-cell patch-clamp configuration was established in current-clamp mode and neurons were excluded from analysis if they showed a resting membrane potential (Vm) more positive than -55 mV, and/or had an action potential that did not overshoot [?5 mV. Data from current-clamp recordings were sampled at 10 kHz and filtered at 5 kHz.
To examine the current-voltage relationship of the response to drug application, voltage ramps were applied from -100 to 0 mV at a rate of 10 mV/s, before, during, and after drug application. During drug application, voltage ramps were applied only after a steady-state drug response had been achieved. Steady-state whole-cell currents were elicited from a holding potential of -60 mV unless otherwise stated. Projection neurons were tested for their response to bath application of dopamine (DA, 50 lM), and the D1 receptor selective agonist, (1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran (A68930, 50 lM).
To examine the effects of DA on stimulus-evoked postsynaptic potentials, a concentric stimulating electrode (FHC, Bowdoinham, ME) was placed in the white matter tract immediately adjacent to the recorded neuron, and close to the fiber tract of the external capsule immediately adjacent to the BLA. Postsynaptic currents were elicited orthodromically using five low intensity 150 ls squarewave pulses administered once every 5 s. Unless stated otherwise, all synaptic data shown are the average of five consecutive stimuli.
Miniature spontaneous excitatory postsynaptic currents (mEPSCs) were recorded at a holding potential of -60 mV in the presence of tetrodotoxin (TTX, 1 lM) and 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR 95531; Gabazine, 5 lM) to block fast GABA A receptor-mediated inhibitory transmission. All drugs were purchased from Sigma-Aldrich (St. Louis, MO), except for A68930 that was purchased from Tocris Cookson Inc, (Ellisville, MO). Drugs were applied by gravity perfusion at the required concentration in the circulating ACSF.
Single-cell RT-PCR
After obtaining the basic electrophysiological properties of recorded neurons, the cell cytoplasm was aspirated into the recording pipette under visual control, by applying gentle negative pressure. The capillary glass used for making the pipette was previously autoclaved and the pipette contained RNase free patch solution. After aspiration of the neuron the electrode tip was broken off and the contents were expelled into an Eppendorf tube containing 1.5 ll of cell lysis buffer [1XPCR buffer II (Applied Biosystems, Foster City, CA), 1.5 mM MgCl 2 (Applied Biosystems), 0.5% NP40 (USB corporation, Cleveland, OH), 5 mM DTT (Invitrogen, Carlsbad, CA), 50 U/ll RNase Inhibitor (Invitrogen), 10 ng/ll primer V1(dT) 24 and 2.5 mM dNTP mix (Invitrogen)] by applying positive pressure. After 15 s centrifugation, the tubes was incubated in water bath at 70°C for 90 s, and then immediately put on ice for 1 min. A 0.3 ll volume of Reverse Transcriptase (RT) mixture [200 U/ll SuperScript III (Invitrogen), 50 U/ll RNase Inhibitor and 6 lg/ll T4 gene 32 protein (Roche, Basel, Switzerland)] was added to each reaction tube, which were then incubated at 50°C for 5 min, followed by heat-inactivation at 70°C for 10 min. The tubes were immediately put on ice for 1 min, and after 15 s centrifugation, 1 ll of Exonuclease I mixture [19 Exonuclease I buffer and 0.5 U/ll Exonuclease I (NewEngland BioLabs, Ipswich, MA)] was added to each tube. The reaction mixture was then incubated at 37°C for 30 min, heat-inactivated at 80°C for 25 min, and then placed on ice for 1 min. Next, 6 ll of terminal deoxynucleotidyl transferase (TdT) mixture [19 PCR buffer II, 25 mM MgCl 2 (Qiagen Germantown, MD), 100 mM dATP (Invitrogen), 2 U/ll RNaseH (Invitrogen) and 15 U/ll TdT (Invitrogen)] was added to each tube, and the mixture was incubated at 37°C for 15 min followed by heat-inactivation at 70°C for 10 min. The RT product was stored at -20°C before further processing. The RT product in each tube (*13 ll) was divided into four 0.2 ml thin walled PCR tubes (3 ll each). Then, 19 ll of PCR mixture I [19 Buffer (Qiagen), 10 mM dNTP mix, 1 lg/ll primer V3 (dT) 24 and 0.05 U/ll Taq DNA Polymerase (Qiagen)] was added to each tube for the first round of PCR: 95°C for 3 min, 50°C for 2 min and 72°C for 3 min. The tubes were immediately put on ice for 1 min, and 19 ll of PCR mixture II was added, with a composition similar to that of PCR buffer I except that primer V3 (dT) 24 was replaced with the primer V1 (dT) 24 . The sequence of V1 (dT) 24 and V3(dT) 24 primer was 5 0 ATA TGG ATC CGG CGC GCC GTC GAC TTT TTT TTT TTT TTT TTT TTT TTT-3  0 and  5  0 -ATA TCT CGA GGG CGC GCC GGA TCC TTT TTT  TTT TTT TTT TTT TTT TTT-3 0 (Kurimoto et al. 2006) . A 20-cycle PCR amplification was then performed 95°C for 30 s, 67°C for 1 min and 72°C for 3 min with a 6 s extension per cycle using PTC-200 Peltier thermal cycler (MJ Research). The amplified cDNA from each cell was screened for the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a positive control. The amplified cDNA from GAPDH positive cells was subjected to another amplification step using 2 ll of cDNA from each cell as a template and 100 nM of each of the primers. All the primers described in this paper were purchased from GenBank sequences with commercially available Oligo software (IDT Tools, Coralville, IA). The following primers were used: GAPDH, 5 0 -GCC ATC AAC GAC CCC TTC AT-3 0 and 5 0 -TTC ACA CCC ATC ACA AAC AT-3 0 (315 bp product; GenBank accession no M17701); D1R-5 0 -CAG TCC ATG CCA AGA ATT GCC AGA-3 0 and 5 0 -AAT CGA TGC AGA ATG GCT GGG TCT-3 0 (225 bp product; GenBank accession no M35077); D5R-5 0 -AGT CGT GGA GCC TAT GAA CCT GAC-3 0 and 5 0 -GCG TCG TTG GAG AGA TTT GAG ACA-3 0 (517 bp product; GenBank accession no M69118). The PCR master mix was comprised of 109 PCR Buffer, 3 mM MgCl 2 , 10 mM dNTPs, 2.5 U of Taq DNA Polymerase in a final volume of 20 ll. PCR was performed using a 10 min hot start at 95°C followed by a 40 cycle program for GAPDH and D1 (94°C for 40 s, 56°C for 40 s and 72°C for 1 min), for D5 (94°C for 1 min, 58°C for 1 min and 72°C for 1.5 min). PCR products were visualized by staining with ethidium bromide and separated by electrophoresis in 1% agarose gel.
Results
Pattern of localization of D1R subtypes in primate amygdala D 1 -immunoreactivity (-IR) is present throughout the amygdala but is heterogeneously distributed (Fig. 1a and  b) . D 1 -IR is robust in the BLA and lateral subdivisions of the amygdala, is found at moderate levels in the basomedial subdivision and is relatively weak in the central nucleus. Of particular note, there are densely stained patches of D 1 -IR found between the subdivisions of the amygdala, especially between the central nucleus and the more ventral regions. These appear to be analogous to the intercalated cell groups identified in rat amygdala, which stain intensely for D 1 (Fuxe et al. 2003) . D 5 -IR is also present throughout the amygdala but appears more homogeneous than D 1 , though the central nucleus is more lightly labeled than the rest of the structure (Fig. 1c and  d) . When examined at higher magnification, D 1 -IR in the BLA is most intense in a perinuclear reticular network in cell bodies (Fig. 2a) , which has previously been associated with labeling in the Golgi apparatus (Muly et al. 1998; Bordelon-Glausier et al. 2008) . In addition, D 1 -IR can also be identified within the soma outside of this reticular network as well as in the neuropil where a light, granular or punctate pattern can be identified. Within the dense patches of D 1 -IR interposed between the central nucleus and ventral amygdala, neuropil staining is more intense and immunoreactive fibers can be identified (Fig. 2b) . D 5 -IR in the BLA is found in cell bodies and in the neuropil with both puncta and short fibers labeled (Fig. 2c) .
Subcellular distribution of D1R in primate BLA
We next examined the localization of D1Rs in the primate BLA in material prepared for electron microscopy. As anticipated from the light microscopy examination, both D 1 -and D 5 -IR are found in neuronal cell bodies in the BLA. As previously reported in the prefrontal cortex, somatic D 1 -IR is concentrated in the Golgi apparatus of neurons (Fig. 3a) ; however, unlike cortical neurons, D 1 -IR is also found associated with other internal membranes in BLA neurons (Fig. 3b) . In contrast with D 1 -, D 5 -IR is not localized to Golgi complexes, but rather is found associated with other internal membranes (Fig. 3c) . D 5 -IR can also be observed in proximity to the plasma membrane, occasionally adjacent to subsurface membrane structures (Fig. 3c) , analogous to previous reports in the prefrontal cortex (Paspalas and Goldman-Rakic 2004) .
The bulk of immunoreactivity for both D1R subtypes is found in the neuropil and both were widely distributed. Both D 1 -and D 5 -IR were commonly seen in dendritic structures, including spines ( Fig. 4a and b ) and dendritic shafts ( Fig. 4c-e) . These immunoreactive shafts included dendrites that received asymmetric (Fig. 4d ) and symmetric synapses (Fig. 4e) . Glial processes were also observed with label for both D 1 and D 5 (Fig. 4f) . In addition, both D 1 -and D 5 -IR were seen in preterminal axons and axon terminals (Fig. 5) . D1R-IR terminals were often observed to make asymmetric synaptic contacts (Fig. 5a , b, d and e) and were sometimes observed to contain prominent dense core vesicles ( Fig. 5b and d) . In addition, D 1 -IR terminals were occasionally observed making asymmetric synapses onto D 1 -IR dendritic spines ( Fig. 5d and e) . In order to determine if the patterns of neuropil distribution differed for the two D1R receptors, we quantified their distribution in the BLA. We examined randomly collected images of neuropil labeling for each receptor and identified 918 D 1 -IR profiles and 903 D 5 -IR profiles. The patterns of D 1 and D 5 labeling confirmed our impression of widespread distributions and differed significantly ( Fig. 6a ; v 2 = 79.679; p \ 0.0001). Post-hoc testing revealed that D 1 immunoreactivity was more commonly found in dendritic shafts, while D 5 immunoreactivity was more commonly found in axon terminals and preterminal axons.
Subcellular distribution of D1R in rat BLA
In order to compare the distribution of D1R between primate and rat BLA, we performed immunohistochemistry for both D 1 and D 5 in rat brain sections and quantified the distribution of these receptors in BLA. We examined randomly collected images of neuropil labeling for each receptor and identified 526 D 1 -IR profiles and 451 D 5 -IR profiles. Both D 1 and D 5 were widely distributed within rat BLA (Fig. 6b) , as we found in primate BLA. The distributions of the two receptors differed in rat BLA (v 2 = 72.371; p \ .0001). Post-hoc testing revealed that D 1 immunoreactivity was more commonly found in dendritic spines, while D 5 immunoreactivity was more commonly found in axon terminals and glia. When we contrast the distribution of each receptor between the two species, in the rat D 1 is found more frequently in spines and preterminal axons and less commonly in dendritic shafts than we observed in primate while D 5 is found more frequently in dendrites and glia in rat and less frequently in spines compared to primate. On the other hand, the distribution of D1R in the BLA of the two species shares some significant similarities, including relatively more presynaptic localization of the D 5 receptor and relatively more postsynaptic localization of the D 1 receptor.
Overlap of D1R in spines and terminals of primate BLA Our previous work in rhesus monkey prefrontal cortex has indicated an extensive overlap of D 1 and D 5 receptors in populations of dendritic spines and axon terminals (Bordelon-Glausier et al. 2008) . Because both receptors are found commonly in these structures in the BLA as well, we used double-label pre-embedding immunogold and immunoperoxidase methods to determine if the two receptors colocalized in the BLA. While the signal obtained with the pre-embedding immunogold method is weaker than that seen with immunoperoxidase, we did achieve specific labeling, as evidenced by D 1 gold labeling in Golgi complexes (Fig. 7a) . Double-labeled dendrites were frequently observed, regardless of which receptor was labeled with ) were also frequently identified. These labeled dendrites were sometimes observed to receive asymmetric (arrowheads, d) and symmetric (arrowheads, e) synaptic contacts. In addition to label in the dendritic arbors of neurons, label was also observed in glial processes as illustrated in f for a D 1 -IR process. Scale bar is 500 nm gold ( Fig. 7b and c) . Gold signal in spines and terminals was weaker and sometimes difficult to distinguish from background staining; however, examples of D 1 /D 5 doublelabeled spines and terminals were observed (Fig. 7d-g ).
In order to quantify the degree to which the two receptors co-localize in spines and axon terminals, we used a cocktail labeling approach which we have previously used to identify overlapping distributions of proteins (Muly et al. 2001; Bordelon-Glausier et al. 2008 ). The advantage of this method is that the labeling method used for each receptor has the same sensitivity and penetration into tissue, thus minimizing the effect of false negative labeling which is problematic for pre-embedding immunogold labeling. We randomly imaged material labeled with antiserum to D 1 , D 5 or a cocktail of antisera to both receptors and calculated the percentage of spines and terminals labeled for each receptor individually as well as for the two receptors combined. We found that 24.1 ± 1.3% of spines in the BLA contained D 1 -IR, while 18.0 ± 1.4% contained D 5 -IR. The percentage of spines in the BLA labeled individually for the two receptors or the cocktail of both antisera differed significantly ( Fig. 8a ; F 2,1687 = 5.729, p = 0.0033), and post-hoc Scheffe tests confirmed that the percentage of spines labeled for D 5 was significantly less The extensive overlap of D 1 and D 5 in dendritic spines suggests that individual BLA projection neurons must coexpress these receptors. We tested this hypothesis using single-cell RT-PCR on samples obtained from primate BLA projection neurons recorded in in vitro slices (Fig. 9) . Here, we looked for the presence of D 1 and D 5 mRNA in a representative sample of 19 primate projection neurons using available primers based on the rat sequence for each gene. We were able to identify the mRNA for a housekeeping gene, glyceraldehydes-3-phosphate dehydrogenase (GAPDH), in 15/19 neurons and only these neurons were then tested for their expression of D 1 and D 5 mRNA. An mRNA signal for either D 1 or D 5 was detected in 13/15 GAPDH positive samples. An mRNA signal was detected in nine neurons each for D 1 and D 5 . Significantly, 5/9 neurons had mRNA transcripts for both D 1 and D 5 receptors. These results strongly support our hypothesis that individual BLA projection neurons express both D 1 and D 5 receptors. Moreover, given the variable sensitivity of RT-PCR and our use of primers from rat, the degree of co-expression observed with this method is likely an underestimate of D 1 and D 5 co-expression.
We also performed a double-label cocktail analysis for axon terminals in the BLA, as we had for dendritic spines. We next examined the synaptic type and postsynaptic structures of D1R-labeled axon terminals. Of the 26 D 1 positive axon terminals which made identifiable synapses, 22 were asymmetric and four were symmetric. Sixteen of the asymmetric synapses were onto spines, while the remaining six were onto unlabeled dendrites. Three of the symmetric synapses were onto dendrites and the remaining D 1 positive axon terminal formed a symmetric synapse onto an unlabeled spine. Of the 29 D 5 positive axon terminals which made identifiable synapses, 22 were asymmetric and seven were symmetric. Twenty of the asymmetric synapses were onto spines, while the remaining two were onto dendrites. The symmetric synapses were all onto dendrites. In addition, dense core vesicles were frequently observed both in D 1 -IR (29.9%) and D 5 -IR (27.3%) terminals. These data suggest that D1R are positioned to presynaptically modulate a wide variety of inputs, in particular excitatory axospinous inputs. Actions of dopamine and D1R in primate BLA To determine how D1 family receptor activation might modulate neuronal activity in the primate BLA, we used in vitro whole-cell patch-clamp recording from BLA projection neurons to examine the response to exogenous application of either dopamine or the D1R-selective agonist, A68930. To date no study has reported on the basic membrane properties of neurons in the primate BLA. In order to make a direct comparison between the dopamine-evoked response in rodent and primate projection neurons, we first characterized some of the basic membrane properties of projection neurons in the primate BLA, a more detailed analysis of the membrane properties of these neurons is in preparation. As illustrated in Fig. 10 , the voltage response (upper trace) of primate BLA projection neurons to graded injection of either hyperpolarizing or depolarizing current (lower trace) is qualitatively no different from that previously reported for rodent BLA projection neurons (Rainnie et al. 1993; Sah et al. 2003; McDonald et al. 2005) . In response to depolarizing current injection, primate projection neurons often fired an initial doublet of action potentials and then settled down to a relatively rhythmic firing pattern. In the hyperpolarizing direction, voltage deflections of increasing amplitude were characterized by the presence of a time-dependent depolarizing sag that increased in amplitude as the membrane potential became more negative. This depolarizing sag is characteristic of the voltage response seen in rodent BLA projection neurons following activation of the hyperpolarization-activated nonselective cation current, I h . Note the occurrence of spontaneous IPSPs in the voltage traces above -60 mV (Fig. 10) , which reverse polarity at more negative membrane potentials. Similar to the high amplitude and long duration spontaneous IPSPs observed in rodent projection neurons that are mediated by GABA A receptor activation (Rainnie 1999) , the spontaneous IPSPs in primate projection neurons occur at a frequency of *1 Hz and were blocked by prior application of the selective GABA A receptor antagonist, bicuculline methiodide (30 lM, data not shown).
An examination of the resting membrane properties and spike characteristics revealed significant differences in some, but not all, of the properties of primate BLA projection neurons compared to those of a representative sample of rodent projection neurons recorded in the Rainnie laboratory in a parallel study (Table 1) . Primate projection neurons had a significantly lower membrane input resistance (Rm; Primate = 39 ± 5 MX: Rat = 71 ± 3 MX; p \ 0.01). No significant difference was observed in the threshold for action potential generation, and either the rise-time or amplitude of single action potentials. However, the primate action potential half-width was significantly longer than that of the rodent (Primate = 1.1 ± 0.1 ms; Rat = 0.89 ± 0.1 ms; p \ 0.01), which is consistent with the significantly slower decay time seen in primate projection neurons (Primate = 1.5 ± 0.1 ms: Rat = 0.92 ± 0.1 ms; p \ 0.01). Taken together, these data suggested that primate projection neurons expressed many of the same intrinsic membrane currents that are found in projection neurons from the rat BLA, with some differences observed that are likely attributable to the larger size of primate neurons.
Given the similarities in membrane response properties between primate and rat BLA neurons, we predicted that exogenous dopamine would affect the excitability of primate BLA projection neurons in much the same way as it affects rat projection neurons. Consistent with our prediction, application of dopamine (50 lM) caused a reversible 3.8 ± 0.2 mV depolarization of the resting membrane potential of primate projection neurons that was associated with a significant reduction (21%) in the membrane input resistance ( Fig. 11a; control: 35 ± 7 MX; dopamine 27 ± 7 MX, n = 10, p \ 0.05). In voltage clamp mode 20 mV 200 ms 1 nA Fig. 10 The prototypical voltage response (upper trace) of a primate BLA projection neuron in response to transient (750 ms) current injection (lower trace). In response to supra-threshold depolarizing current injection most neurons fire a short burst of action potentials and then settle to a rhythmic pattern of action potential generation. In response to hyperpolarizing current injection projection neurons display a prominent depolarizing sag in the membrane voltage response. Note the occurrence of long duration spontaneous inhibitory synaptic potentials (IPSPs) in most of the voltage traces (Fig. 11b) , exogenous dopamine application was seen to elicit an inward current (59 ± 5.6 pA, n = 17) that persisted in the presence of tetrodotoxin (TTX, 1 lM), and which had an apparent reversal potential of -39 ± 2.1 mV (n = 17). These data are consistent with previous studies in the rat BLA in which a similar dopamine-evoked inward current observed in projection neurons was mimicked by the D1R selective agonist, dihydrexidine, and blocked by the D1R selective antagonist SCH 23390 (Levita et al. 2003; Pickel et al. 2006) .
Moreover, in control aCSF application of dopamine (50 lM) routinely caused a doubling in the frequency of the spontaneous IPSPs in primate projections neurons (Fig. 12) . Hence, in aCSF spontaneous GABA A receptormediated IPSPs occurred at a frequency of 0.85 ± 0.2 Hz (Fig. 12a, n = 8 ). In the presence of dopamine (50 lM) the frequency of spontaneous IPSPs increased to 1.65 ± 0.3 Hz (Fig. 12b , n = 8, p \ 0.01), and returned back to control values (0.7 ± 0.4 Hz) following washout with aCSF (Fig. 12c, n = 8) .
Our localization studies found both D 1 and D 5 receptors present in axon terminals making asymmetric contacts with the spines of primate BLA projection neurons, similar to observations of the D 1 receptor in the rat BLA (Pickel et al. 2006) . Consequently, we next examined the effects of exogenous application of the D1R selective agonist, A68930 (50 lM), on the amplitude and frequency of miniature excitatory postsynaptic currents (mEPSCs) recorded in primate projection neurons in the presence of TTX and GABA receptor antagonists. As illustrated in Fig. 13 , application of A68930 increased the frequency (control 4.8 ± 1.1 Hz; A68930 6.8 ± 1.7 Hz; n = 6, p \ 0.05), but not the amplitude (control 14.6 ± 0.6 pA; A68930 14.3 ± 0.9 pA; n = 6, p [ 0.05), of mEPSCs in primate projection neurons, suggesting a presynaptic site of D1R action. Prior application of the non-selective D1R antagonist (SCH 23390, 20 lM), which has no effect on either the amplitude or the frequency of mEPSCs by itself, fully blocked the A69830 induced increase in mEPSC frequency (SCH 23390 3.7 ± 0.7 Hz; A68930 in SCH 23390 3.3 ± 0.6 Hz, n = 6, p [ 0.05; Fig. 14) .
Discussion
Dopamine activation of D1 family dopamine receptors plays a critical role in amygdala functioning. Dopamine Table 1 A comparative analysis of some basic membrane properties of BLA projection neurons of the rat and primate levels are increased in the amygdala by conditioned fear stress (Yokoyama et al. 2005) and D1R activation in the BLA is necessary for the development of conditioned fear (Lamont and Kokkinidis 1998; Nader and LeDoux 1999; Guarraci et al. 1999; Greba and Kokkinidis 2000; Macedo et al. 2007) . The data presented here provide the first detailed description of the distribution of D1 family dopamine receptors in the primate and rat BLA. In addition, we present physiological evidence for dopamine actions in the primate BLA that are similar to those reported in the rat. Our results demonstrate a complex and widespread distribution of both D 1 and D 5 receptors in primate BLA with each receptor found both postsynaptically in the dendritic arbor of BLA neurons and presynaptically in axon terminals and preterminal axons. Our electrophysiological data are consistent with previous observations that dopamine and D1R stimulation can directly depolarize and excite both BLA projection neurons and interneurons (Levita et al. 2003; Loretan et al. 2004; Kroner et al. 2005; Pickel et al. 2006) . Moreover, we show that dopamine can also act presynaptically to increase the probability of neurotransmitter release from glutamatergic terminals. Furthermore, while previous studies have highlighted D 1 localization in intercalated cell masses, our finding that one quarter of dendritic spines in the BLA contain either D 1 , or both D 1 and D 5 indicate that dopamine acting on these receptors can have powerful effects by directly modulating the excitability of BLA projection neurons. Thus, dopamine's actions in primate amygdala are a complex mix of post-and presynaptic actions at several sites in intraamygdala circuits.
This study also allowed us to compare the distributions of D1R subtypes between two species, the rhesus monkey and rat. Previously, only the localization of the D 1 subtype in rat amygdala has been examined qualitatively and with somewhat divergent results. Pickel et al. (2006) reported D 1 -IR mainly in cell bodies and dendrites, with spines and axon terminals seen more rarely. Alternately, Pinto and Sesack (2008) reported D 1 -IR was most commonly seen in dendritic spines, with dendritic shafts, axonal elements and glia less commonly seen. Our data confirmed that label is more common in the dendritic arbor than the axon arbor. In comparing the localization profiles, we observed in monkey and rat, there were significant similarities noted. Both receptors were widely distributed in both species. Labeling was more common in the dendritic arbor for D 1 in both species and in the axonal arbor for D 5 in both species. The D 5 receptor has a higher affinity for dopamine than D 1 (Sunahara et al. 1991; Weinshank et al. 1991 ) and our results in rat and monkey suggest that presynaptic action at a low concentration of dopamine is an important and conserved aspect of dopaminergic regulation of the BLA. There were also some differences between the two species, in particular D 1 was found more frequently in spines and less so in dendrites in rats, while D 5 was found less frequently in spines and more so in dendrites in rats compared to monkeys. Our physiological data in monkey was notable for its similarities with previous studies in rat. In future studies it will be interesting to examine whether there are any major differences in the postsynaptic responses to dopamine between the two species.
The differential distribution of D 1 and D 5 receptors within cellular compartments of the rat and primate BLA may help to explain some of the apparent contradictions in the literature regarding the physiological actions of dopamine within this nucleus. For example, afferent input from the medial prefrontal cortex (mPFC) has been reported to inhibit firing of BLA projection neurons and suppress sensory input from the association cortex by activating inhibitory interneurons in the BLA Grace 2001, 2002 ; but see Likhtik et al. 2005) . Dopamine was reported to facilitate the induction of LTP in the BLA by attenuating the inhibitory response to mPFC activation and facilitating sensory input from the association cortex (Rosenkranz and Grace 2001) . However, consistent with our observation in the primate BLA, evidence from several rodent studies suggests that dopamine acting via D1R receptors directly excites interneurons in the BLA and increases the occurrence of spontaneous IPSPs in projection neurons (Levita et al. 2003; Loretan et al. 2004; Marowsky et al. 2005) . Many recent studies have focused on the intercalated cell masses as key to information processing and dopamine action in the amygdala. Evidence from rat and primate suggests that efferents from the mPFC synapse with, and excite GABAergic neurons of the paracapsular intercalated cell masses (pICMs; Ghashghaei and Barbas 2002; Berretta et al. 2005) . In turn, activation of the pICMs results in feed-forward inhibition of BLA projection neurons (Marowsky et al. 2005) . Significantly, dopamine has been shown to gate LTP in the BLA by inhibiting the GABAergic pICMs through D1R receptor activation and hence suppressing feed-forward inhibition (Bissiere et al. 2003; Marowsky et al. 2005) . Our data highlight the importance of dopamine actions at D1Rs within the BLA itself and suggest that differential distribution of D 1 and D 5 receptors between intrinsic BLA interneurons and paracapsular ICMs could explain the diametrically opposite actions of D1R receptor activation in these two GABAergic cell populations. At first glance, a D1R receptor-mediated increase in local circuit inhibition and decreased feed-forward inhibition appears contradictory, particularly in light of our observation that D1R receptor activation also excites BLA projection neurons (current study; Pickel et al. 2006) . However, depolarization of BLA projection neurons would a In a cell that showed an increase in frequency of mEPSCs to A6890 (see Fig. 13a ), application of SCH 23390 (20 lM; left traces) had no effect on the frequency or amplitude of spontaneous mEPSCs, but fully blocked the increased mEPSC frequency observed in the presence of the D1R agonist (A68930, 50 lM; right traces). b Cumulative fraction plots showing that application of A68930 (50 lM) has no effect on either the amplitude (left plot) or the frequency (right plot) of mEPSCs in the presence of the D1R selective antagonist SCH 23390. c A histogram showing the group data for the SCH 23390 blockade of the A68930-induced increase in mEPSC frequency (n = 6) move them closer to the activation range of an intrinsic membrane potential oscillation (Pape et al. 1998 ). Recently we and other have shown that spontaneous IPSPs in BLA projection neurons can increase spike timing precision by facilitating intrinsic membrane potential oscillations (Woodruff and Sah 2007; Jasnow et al. 2008; Rainnie and Ressler 2009) . Together these data suggest that D1R receptor activation could facilitate the induction of LTP by increasing spike timing precision and abolishing feedforward inhibition of sensory inputs. Previous work has found that D1R agonists do not appear to preferentially couple to adenylate cyclase in the amygdala (Leonard et al. 2003) , but rather couple to phosphoinositol hydrolysis (Undie and Friedman 1990) . Studies from transgenic mice have suggested that D1R coupling to phospholipase C is mediated by the D 5 , but not the D 1 receptor (Friedman et al. 1997; Sahu et al. 2008) . We found that while the D 5 receptor is found in significant numbers of BLA spines, the D 1 receptor is more abundant, thus the alternate coupling observed in the amygdala is not solely due to a different D1R subtype present there. It remains to be determined if the different D1R signaling in the amygdala is due to different availability of signal transduction proteins there or possible heterodimerization of D1R subtypes with each other or another receptor.
The significance of the different patterns of D 1 and D 5 localization we observed in the BLA depends on the functional differences between the two D1R subtypes. Despite a lack of pharmacological tools that adequately differentiate the two receptors, a growing body of evidence points to important differences between the two. Investigators using transgenic mice or antisense oligonucleotide injections have found that D 5 , but not D 1 receptors, are necessary for cocaine discrimination as well as dopamineevoked acetylcholine release in the hippocampus (Filip et al. 2000; Hersi et al. 2000; Laplante et al. 2004 ). Furthermore, D 1 directly interacts with the NMDA receptor (Lee et al. 2002) , while D 5 directly interacts with the GABA A receptor (Liu et al. 2000) . Intriguingly, the two D1R subtypes appear to play differential roles in modulating synaptic plasticity. Corticostriatal long-term potentiation is disrupted in D 1 knockout mice, while blockade of the remaining D 5 receptors prevents induction of long-term depression (Centonze et al. 2003) . In particular, the D 5 receptor has a tenfold higher affinity for dopamine, the endogenous ligand (Sunahara et al. 1991; Weinshank et al. 1991) . This observation, coupled with the D 5 receptor's relatively preferential localization in presynaptic compartments suggests that in the BLA presynaptic D1R effects might dominate at low levels of dopamine release and that as the activity of dopaminergic inputs increased, postsynaptic actions might become more prominent.
